Malvern, United Kingdom

Mark Pallen


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Worcs, GB (2005)
  • Malvern, GB (2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Mark Pallen

Introduction

Mark Pallen is a notable inventor based in Malvern, GB. He has made significant contributions to the field of microbiology, particularly in the development of antibodies and vaccines targeting staphylococcal infections. With a total of two patents to his name, Pallen's work has the potential to impact medical treatments significantly.

Latest Patents

Pallen's latest patents focus on surface proteins that generate polyclonal and monoclonal antibodies. These antibodies are cross-reactive to both coagulase-positive and coagulase-negative bacteria. The patents describe methods for generating these antibodies from surface proteins isolated based on common characteristics. Additionally, vaccines comprising an immunologically effective amount of these proteins are provided, which can be used for the treatment or protection against various staphylococcal infections.

Career Highlights

Throughout his career, Mark Pallen has worked with several organizations, including Inhibitex, Inc. and the Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth, Near Dublin. His work has been instrumental in advancing the understanding of bacterial infections and developing effective treatments.

Collaborations

Some of Pallen's notable coworkers include Timothy James Foster and Fiona Roche. Their collaborative efforts have contributed to the advancements in the field of microbiology and the development of innovative solutions for bacterial infections.

Conclusion

Mark Pallen's contributions to the field of microbiology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments for staphylococcal infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…